FDA Extends Review of Sanofi’s Tolebrutinib for Pr...
Category : Product Related Updates 24 September 2025The U.S. Food and Drug Administration (FDA) has extended the target action date for Sanofi’s t...
The U.S. Food and Drug Administration (FDA) has extended the target action date for Sanofi’s t...
Ascletis Pharma Inc. (HKEX: 1672) announced positive topline data from the ASC47-103 trial, showing...
London, UK — AMO Pharma Limited, a clinical-stage specialty biopharmaceutical company focused...
ALS (amyotrophic lateral sclerosis) is one of the most devastating diagnoses anyone can receive. A d...
Kiora Pharmaceuticals, Inc., a clinical-stage biotechnology company developing advanced therapies fo...